Jayson Bedford
Stock Analyst at Raymond James
(3.86)
# 673
Out of 5,090 analysts
323
Total ratings
54.9%
Success rate
7.54%
Average return
Main Sectors:
Stocks Rated by Jayson Bedford
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AXGN Axogen | Maintains: Outperform | $20 → $27 | $33.32 | -18.97% | 2 | Oct 30, 2025 | |
| ISRG Intuitive Surgical | Maintains: Outperform | $592 → $603 | $575.34 | +4.81% | 9 | Oct 22, 2025 | |
| CBLL CeriBell | Initiates: Strong Buy | $19 | $19.72 | -3.65% | 1 | Oct 21, 2025 | |
| ABT Abbott Laboratories | Maintains: Outperform | $141 → $146 | $125.08 | +16.73% | 30 | Oct 16, 2025 | |
| JNJ Johnson & Johnson | Maintains: Outperform | $174 → $209 | $201.93 | +3.50% | 24 | Oct 15, 2025 | |
| ZBH Zimmer Biomet Holdings | Maintains: Outperform | $104 → $113 | $94.28 | +19.86% | 9 | Aug 8, 2025 | |
| ICUI ICU Medical | Maintains: Strong Buy | $187 → $180 | $142.51 | +26.31% | 21 | Aug 8, 2025 | |
| MMSI Merit Medical Systems | Maintains: Outperform | $108 → $102 | $83.43 | +22.26% | 28 | Jul 31, 2025 | |
| DXCM DexCom | Maintains: Strong Buy | $99 → $102 | $65.49 | +55.75% | 31 | Jul 31, 2025 | |
| BSX Boston Scientific | Maintains: Strong Buy | $121 → $124 | $97.52 | +27.15% | 26 | Jul 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $328 → $360 | $304.49 | +18.23% | 27 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $204 → $185 | $141.68 | +30.58% | 7 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $275 → $270 | $193.96 | +39.20% | 3 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $12 → $10 | $13.47 | -25.76% | 14 | Jan 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $227 → $271 | $120.50 | +124.90% | 12 | Dec 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $17.27 | - | 10 | Nov 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $20.92 | - | 13 | Apr 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $86.19 | - | 20 | Feb 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $18.54 | - | 6 | Jan 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $101.36 | - | 14 | Aug 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | n/a | $6.62 | - | 4 | Mar 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $75 → $86 | $74.97 | +14.71% | 4 | Nov 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $0.73 | - | 5 | Aug 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $13.23 | - | 3 | Jan 2, 2018 |
Axogen
Oct 30, 2025
Maintains: Outperform
Price Target: $20 → $27
Current: $33.32
Upside: -18.97%
Intuitive Surgical
Oct 22, 2025
Maintains: Outperform
Price Target: $592 → $603
Current: $575.34
Upside: +4.81%
CeriBell
Oct 21, 2025
Initiates: Strong Buy
Price Target: $19
Current: $19.72
Upside: -3.65%
Abbott Laboratories
Oct 16, 2025
Maintains: Outperform
Price Target: $141 → $146
Current: $125.08
Upside: +16.73%
Johnson & Johnson
Oct 15, 2025
Maintains: Outperform
Price Target: $174 → $209
Current: $201.93
Upside: +3.50%
Zimmer Biomet Holdings
Aug 8, 2025
Maintains: Outperform
Price Target: $104 → $113
Current: $94.28
Upside: +19.86%
ICU Medical
Aug 8, 2025
Maintains: Strong Buy
Price Target: $187 → $180
Current: $142.51
Upside: +26.31%
Merit Medical Systems
Jul 31, 2025
Maintains: Outperform
Price Target: $108 → $102
Current: $83.43
Upside: +22.26%
DexCom
Jul 31, 2025
Maintains: Strong Buy
Price Target: $99 → $102
Current: $65.49
Upside: +55.75%
Boston Scientific
Jul 24, 2025
Maintains: Strong Buy
Price Target: $121 → $124
Current: $97.52
Upside: +27.15%
May 27, 2025
Maintains: Outperform
Price Target: $328 → $360
Current: $304.49
Upside: +18.23%
May 7, 2025
Maintains: Outperform
Price Target: $204 → $185
Current: $141.68
Upside: +30.58%
Aug 2, 2024
Maintains: Outperform
Price Target: $275 → $270
Current: $193.96
Upside: +39.20%
Jan 9, 2024
Maintains: Outperform
Price Target: $12 → $10
Current: $13.47
Upside: -25.76%
Dec 20, 2023
Maintains: Outperform
Price Target: $227 → $271
Current: $120.50
Upside: +124.90%
Nov 16, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $17.27
Upside: -
Apr 24, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $20.92
Upside: -
Feb 6, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $86.19
Upside: -
Jan 5, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $18.54
Upside: -
Aug 24, 2022
Downgrades: Market Perform
Price Target: n/a
Current: $101.36
Upside: -
Mar 5, 2021
Downgrades: Underperform
Price Target: n/a
Current: $6.62
Upside: -
Nov 5, 2020
Maintains: Outperform
Price Target: $75 → $86
Current: $74.97
Upside: +14.71%
Aug 2, 2019
Downgrades: Market Perform
Price Target: n/a
Current: $0.73
Upside: -
Jan 2, 2018
Downgrades: Market Perform
Price Target: n/a
Current: $13.23
Upside: -